ZKSCAN3 and Familial prostate cancer: Third, ZKSCAN3 protein overexpression was observed in none of normal prostate tissues versus 49% of prostate cancer specimens, while ZKSCAN3 gene amplification was detected in none of primary tumors, 20% of lymph node metastases, and 26% of bone metastases [7].